XML 30 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financing Receivables: (Details 2) (USD $)
In Millions, unless otherwise specified
9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2013
Major Markets
Dec. 31, 2012
Major Markets
Sep. 30, 2013
Growth Markets
Dec. 31, 2012
Growth Markets
Sep. 30, 2013
Lease receivables
Dec. 31, 2012
Lease receivables
Dec. 31, 2011
Lease receivables
Sep. 30, 2013
Lease receivables
Major Markets
Dec. 31, 2012
Lease receivables
Major Markets
Dec. 31, 2011
Lease receivables
Major Markets
Sep. 30, 2013
Lease receivables
Growth Markets
Dec. 31, 2012
Lease receivables
Growth Markets
Dec. 31, 2011
Lease receivables
Growth Markets
Sep. 30, 2013
Loan receivables
Dec. 31, 2012
Loan receivables
Dec. 31, 2011
Loan receivables
Sep. 30, 2013
Loan receivables
Major Markets
Dec. 31, 2012
Loan receivables
Major Markets
Dec. 31, 2011
Loan receivables
Major Markets
Sep. 30, 2013
Loan receivables
Growth Markets
Dec. 31, 2012
Loan receivables
Growth Markets
Dec. 31, 2011
Loan receivables
Growth Markets
Financing Receivables                                                
Ending Balance $ 21,681 $ 22,510 $ 15,747 $ 16,701 $ 5,934 $ 5,808 $ 8,809 $ 9,174   $ 6,705 $ 7,036   $ 2,104 $ 2,138   $ 12,871 $ 13,336   $ 9,042 $ 9,666   $ 3,830 $ 3,670  
Collectively evaluated for impairment 21,395 22,254 15,629 16,570 5,767 5,684                                    
Individually evaluated for impairment 285 256 118 131 167 125                                    
Allowance for Credit Losses                                                
Allowance for credit losses, beginning balance 318 307 180 203 138 104 106 114 118 42 59 79 64 55 40 218 204 189 92 121 125 126 84 64
Write-offs (30) (15) (21) (14) (9) (1)                                    
Provision 40 28 (26) (9) 66 38                                    
Other (4) (2)    0 (4) (2)                                    
Allowance for credit losses, ending balance 324 318 134 180 190 138 106 114 118 42 59 79 64 55 40 218 204 189 92 121 125 126 84 64
Collectively evaluated for impairment 77 98 40 69 37 29                                    
Individually evaluated for impairment $ 247 $ 220 $ 94 $ 111 $ 153 $ 109